Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

NCT05211193 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder (OAB)
Failed Any OAB Pharmacotherapy

Interventions

DEVICE: eTNM delivered by URIS I nerve stimulation device

Sponsor

Stimvia s.r.o.